
To evaluate treatment modalities of T4 larynx cancer in older adults using SEER‐Medicare. Older patients with T4 larynx cancer had similar survival rates when treated with CR, SR, and SCR. Average total health care costs were not significantly different between modalities. Patients not eligible for triple‐modality could consider these other treatment options.
Like
Save
Share